Cytotoxic activity of pyrimethanil on human testicular teratocarcinoma NT2/D1 cells

Key Points

• Pyrimethanil significantly reduces cell viability in NT2/D1 cells, indicating strong cytotoxic effects.
• Cell viability decreased to 30% after treatment with 50 µM of pyrimethanil, demonstrating dose-dependent response.
• Analysis involved assessing cell viability through standard cytotoxicity assays in human testicular teratocarcinoma cells.
• These findings suggest potential therapeutic applications of pyrimethanil, pending further investigation for clinical relevance.